43 /100
MEDIUM RISK
Score updated Jul 13, 2026

ANGO — AngioDynamics, Inc. Dilution Risk Tracker

Track ANGO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ANGO — Get alerts when the score changes →

As of July 13, 2026, AngioDynamics, Inc. (ANGO) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. AngioDynamics, Inc. has a market capitalization of $474.34M, 41.32M shares outstanding, 147 institutional holders tracked. Key dilution vectors include approximately 7 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
65
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
💰 Capital Raise 15%
• Under 12 months cash (7mo)
🔔 Track ANGO — Get forecast alerts →

💹 Market Data

Market Cap$474.34M
Shares Outstanding41.32M
Float34.61M
Cash$51.88M
Debt$124.41M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 8.4% shares (2026Q1 vs prior)
147 institutional holders · 43.18M shares
#1 BlackRock, Inc. 3.69M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 3.45M shares
#3 Point72 Asset Management, L.P. 3.18M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.36M
Days to Cover2.9
% of Float3.9%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for ANGO Shareholders

AngioDynamics, Inc. (ANGO) has a DilutionScore of 43/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

Cash runway is a key watch item: ANGO has approximately 7 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for ANGO in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ANGO alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track ANGO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ANGO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ANGO
📊 ANGO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ANGO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.